Patents by Inventor John R. Wilson

John R. Wilson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240143024
    Abstract: An example method is performed at a device with a display and a biometric sensor. While the device is in a locked state, the method includes displaying a log-in user interface that is associated with logging in to a first and second user account. While displaying the log-in user interface, the method includes, receiving biometric information, and in response to receiving the biometric information: when the biometric information is consistent with biometric information for the first user account and the first user account does not have an active session, displaying a prompt to input a log-in credential for the first user account; and when the biometric information is consistent with biometric information for the second user account and the second user account does not have an active session on the device, displaying a prompt to input a log-in credential for the second user account.
    Type: Application
    Filed: January 9, 2024
    Publication date: May 2, 2024
    Inventors: Raymond S. Sepulveda, Chun Kin Minor Wong, Patrick L. Coffman, Dylan R. Edwards, Eric Lance Wilson, Gregg S. Suzuki, Christopher I. Wilson, Lawrence Y. Yang, Andre Souza Dos Santos, Jeffrey T. Bernstein, Duncan R. Kerr, John B. Morrell
  • Publication number: 20240132820
    Abstract: Improved cell culture devices and related methods that overcome the limitations of prior devices and methods, by creating devices that can integrate a variety of novel attributes. These various attributes include the use of gas permeable material and medium volumes that exceed conventional devices as well as compartments that can facilitate the long term study of high density cultures with reduced disruption of the culture environment, the ability to study the migration of items of interest including substances such as chemokine, track the movement of cells, and monitor cell to cell interactions.
    Type: Application
    Filed: December 29, 2023
    Publication date: April 25, 2024
    Inventors: John R. Wilson, Daniel P. Welch
  • Patent number: 11963979
    Abstract: An in vitro expansion process for rapid expansion of antigen specific T cells, such as allogeneic antigen specific T cells comprising the steps culturing in a gas permeable vessel a population of PBMCs (such as allogeneic PBMCs) in the presence of antigen, for example a peptide or peptide mix relevant to a target antigen(s), in the presence of an exogenous cytokine characterized in that the expansion to provide the desired population of T cells is 14 days or less, for example 9, 10, 11 or 12 days, such as 10 days. The disclosure also extends to T cell populations generated by and obtained from the method and the use of same in therapy.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: April 23, 2024
    Assignees: AlloVir, Inc., Baylor College of Medicine, Wilson Wolf Manufacturing Corporation
    Inventors: Rainer Ludwig Knaus, Katy Rebecca Newton, Juan Vera, Ann Leen, Cliona Rooney, John R. Wilson
  • Patent number: 11946722
    Abstract: A detector for detecting the removal and/or insertion of a weapon out of and/or into a holster. The detector may transmit a message each time the weapon is removed from the holster. A recording system may receive the message and determine whether or not it will begin recording the data it captures. A detector may detect the change in a magnitude of an inductance and/or an impedance of a circuit to detect insertion and removal of the weapon into and out of the holster. The holster is configured to couple to the detector to position the detector to detect insertion and removal of the weapon. An adhesive tape may couple a detector to a holster.
    Type: Grant
    Filed: May 2, 2023
    Date of Patent: April 2, 2024
    Assignee: Axon Enterprise, Inc.
    Inventors: Daniel Joseph Wagner, Nache D. Shekarri, Jonathan R. Hatcher, John W. Wilson, Andrew G. Terajewicz, Lucas Kraft, Brian Piquette, Zachary B. Williams, Elliot William Weber, Jason W. Haensly
  • Publication number: 20240101952
    Abstract: Novel methods and apparatus are disclosed for cell culture and cell recovery. The methods and apparatus simplify the process of cell separation from media, minimize potential damage to gas permeable devices during fluid handling, and allow closed system automated cell culture and cell recovery from gas permeable devices.
    Type: Application
    Filed: November 30, 2023
    Publication date: March 28, 2024
    Inventors: Daniel P. WELCH, John R. WILSON
  • Publication number: 20240084255
    Abstract: An improved method of culturing cells for cell therapy applications that includes growing desired cells in the presence of antigen-presenting cells and/or feeder cells and with medium volume to surface area ratio of up to 1 ml/cm2 if the growth surface is not comprised of gas permeable material and up to 2 ml/cm2 if the growth surface is comprised of gas permeable material. The desired cells are at a surface density of less than 0.5×106 cells/cm2 at the onset of a production cycle, and the surface density of the desired cells plus the surface density of the antigen presenting cells and/or feeder cells are at least about 1.25×105 cells/cm2.
    Type: Application
    Filed: November 16, 2023
    Publication date: March 14, 2024
    Inventors: Juan F. VERA, Cliona M. ROONEY, Ann M. LEEN, John R. WILSON
  • Patent number: 11925902
    Abstract: A thermally reflective membrane apparatus comprises a housing structure, and a thermally reflective membrane contained within the housing structure. The thermally reflective membrane comprises a semipermeable structure, and a porous, thermally reflective structure physically contacting the semipermeable structure. The porous, thermally reflective structure comprises discrete thermally reflective particles, and a binder material coupling the discrete thermally reflective particles to one another and the semipermeable structure. A fluid treatment system and method of treating a fluid are also described.
    Type: Grant
    Filed: September 1, 2020
    Date of Patent: March 12, 2024
    Assignee: Battelle Energy Alliance, LLC
    Inventors: John R. Klaehn, Christopher J. Orme, Aaron D. Wilson, Birendra Adhikari, Frederick F. Stewart, Seth W. Snyder
  • Patent number: 11914419
    Abstract: An example method is performed at a device with a display and a biometric sensor. While the device is in a locked state, the method includes displaying a log-in user interface that is associated with logging in to a first and second user account. While displaying the log-in user interface, the method includes, receiving biometric information, and in response to receiving the biometric information: when the biometric information is consistent with biometric information for the first user account and the first user account does not have an active session, displaying a prompt to input a log-in credential for the first user account; and when the biometric information is consistent with biometric information for the second user account and the second user account does not have an active session on the device, displaying a prompt to input a log-in credential for the second user account.
    Type: Grant
    Filed: July 12, 2022
    Date of Patent: February 27, 2024
    Assignee: APPLE INC.
    Inventors: Raymond S. Sepulveda, Chun Kin Minor Wong, Patrick L. Coffman, Dylan R. Edwards, Eric Lance Wilson, Gregg S. Suzuki, Christopher I. Wilson, Lawrence Y. Yang, Andre Souza Dos Santos, Jeffrey T. Bernstein, Duncan R. Kerr, John B. Morrell
  • Patent number: 11891595
    Abstract: Improved cell culture devices and related methods that overcome the limitations of prior devices and methods, by creating devices that can integrate a variety of novel attributes. These various attributes include the use of gas permeable material and medium volumes that exceed conventional devices as well as compartments that can facilitate the long term study of high density cultures with reduced disruption of the culture environment, the ability to study the migration of items of interest including substances such as chemokine, track the movement of cells, and monitor cell to cell interactions.
    Type: Grant
    Filed: March 24, 2023
    Date of Patent: February 6, 2024
    Assignee: Wilson Wolf Manufacturing LLC
    Inventors: John R. Wilson, Daniel P. Welch
  • Patent number: 11873474
    Abstract: Novel methods and apparatus are disclosed for cell culture and cell recovery. The methods and apparatus simplify the process of cell separation from media, minimize potential damage to gas permeable devices during fluid handling, and allow closed system automated cell culture and cell recovery from gas permeable devices.
    Type: Grant
    Filed: September 16, 2021
    Date of Patent: January 16, 2024
    Assignee: Wilson Wolf Manufacturing
    Inventors: Daniel P. Welch, John R. Wilson
  • Publication number: 20240002797
    Abstract: Production and use of novel therapeutic cells, called T-Vehicles, in the allogeneic Adoptive Cell Therapy setting allows a wide range of therapeutic benefits to accrue with minimal or no risk of GVHD. T-Vehicles are created from donor T cells that are altered to contain therapeutic attributes that do not include their native antigen receptors and can deliver therapeutic benefits irrelevant of their native antigen specificity. T-Vehicles can possess highly restricted native antigen specificity that renders them unable to recognize antigens present on normal cells and incapable of initiating GVHD, making them ideal transport vehicles to deliver various therapeutic attributes in vivo. In essence, production and use of T-Vehicles is a paradigm shift that opens the door to therapeutic application of T cells in ways not previously contemplated, independent of whether or not there is an HLA match between the donor and the recipient.
    Type: Application
    Filed: May 17, 2023
    Publication date: January 4, 2024
    Inventors: Juan F. Vera, Cliona M. Rooney, Ann M. Leen, John R. Wilson
  • Publication number: 20230383250
    Abstract: Production and use of novel therapeutic cells, called T-Vehicles, in the allogeneic Adoptive Cell Therapy setting allows a wide range of therapeutic benefits to accrue with minimal or no risk of GVHD. T-Vehicles are created from donor T cells that are altered to contain therapeutic attributes that do not include their native antigen receptors and can deliver therapeutic benefits irrelevant of their native antigen specificity. T-Vehicles can possess highly restricted native antigen specificity that renders them unable to recognize antigens present on normal cells and incapable of initiating GVHD, making them ideal transport vehicles to deliver various therapeutic attributes in vivo. In essence, production and use of T-Vehicles is a paradigm shift that opens the door to therapeutic application of T cells in ways not previously contemplated, independent of whether or not there is an HLA match between the donor and the recipient.
    Type: Application
    Filed: May 17, 2023
    Publication date: November 30, 2023
    Inventors: Juan F. Vera, Cliona M. Rooney, Ann M. Leen, John R. Wilson
  • Patent number: 11821002
    Abstract: An improved method of culturing cells for cell therapy applications that includes growing desired cells in the presence of antigen-presenting cells and/or feeder cells and with medium volume to surface area ratio of up to 1 ml/cm2 if the growth surface is not comprised of gas permeable material and up to 2 ml/cm2 if the growth surface is comprised of gas permeable material. The desired cells are at a surface density of less than 0.5×106 cells/cm2 at the onset of a production cycle, and the surface density of the desired cells plus the surface density of the antigen presenting cells and/or feeder cells are at least about 1.25×105 cells/cm2.
    Type: Grant
    Filed: March 7, 2022
    Date of Patent: November 21, 2023
    Assignees: Baylor College of Medicine, Wilson Wolf Manufacturing
    Inventors: Juan F. Vera, Cliona M. Rooney, Ann M. Leen, John R. Wilson
  • Publication number: 20230357721
    Abstract: The present invention encompasses methods and compositions for the generation and use of cytotoxic T lymphocytes that target multiple viruses or that are specific for multiple tumor antigens. In specific embodiments, the generation methods employ use of certain cytokines to promote proliferation and reduce cell death in an activated T cell population and/or that employ a particular bioreactor having a gas permeable membrane.
    Type: Application
    Filed: July 18, 2023
    Publication date: November 9, 2023
    Inventors: Ann Marie Leen, Ulrike Gerdemann, Cliona M. Rooney, Juan F. Vera Valdes, John R. Wilson
  • Publication number: 20230303967
    Abstract: This invention relates to methods and devices that improve cell culture efficiency. They include the use of gas permeable culture compartments that reduce the use of space while maintaining uniform culture conditions, and are more suitable for automated liquid handling. They include the integration of gas permeable materials into the traditional multiple shelf format to resolve the problem of non-uniform culture conditions. They include culture devices that use surfaces comprised of gas permeable, plasma charged silicone and can integrate traditional attachment surfaces, such as those comprised of traditional tissue culture treated polystyrene. They include culture devices that integrate gas permeable, liquid permeable membranes. A variety of benefits accrue, including more optimal culture conditions during scale up and more efficient use of inventory space, incubator space, and disposal space. Furthermore, labor and contamination risk are reduced.
    Type: Application
    Filed: May 26, 2023
    Publication date: September 28, 2023
    Inventor: John R. Wilson
  • Publication number: 20230265383
    Abstract: This invention relates to methods and devices that improve cell culture efficiency. They include the use of gas permeable culture compartments that reduce the use of space while maintaining uniform culture conditions, and are more suitable for automated liquid handling. They include the integration of gas permeable materials into the traditional multiple shelf format to resolve the problem of non-uniform culture conditions. They include culture devices that use surfaces comprised of gas permeable, plasma charged silicone and can integrate traditional attachment surfaces, such as those comprised of traditional tissue culture treated polystyrene. They include culture devices that integrate gas permeable, liquid permeable membranes. A variety of benefits accrue, including more optimal culture conditions during scale up and more efficient use of inventory space, incubator space, and disposal space. Furthermore, labor and contamination risk are reduced.
    Type: Application
    Filed: April 7, 2023
    Publication date: August 24, 2023
    Inventor: John R. Wilson
  • Publication number: 20230227762
    Abstract: Improved cell culture devices and related methods that overcome the limitations of prior devices and methods, by creating devices that can integrate a variety of novel attributes. These various attributes include the use of gas permeable material and medium volumes that exceed conventional devices as well as compartments that can facilitate the long term study of high density cultures with reduced disruption of the culture environment, the ability to study the migration of items of interest including substances such as chemokine, track the movement of cells, and monitor cell to cell interactions.
    Type: Application
    Filed: March 24, 2023
    Publication date: July 20, 2023
    Inventors: John R. Wilson, Daniel P. Welch
  • Publication number: 20230114971
    Abstract: The present invention encompasses methods and compositions for the generation and use of cytotoxic T lymphocytes that target multiple viruses or that are specific for multiple tumor antigens. In specific embodiments, the generation methods employ use of certain cytokines to promote proliferation and reduce cell death in an activated T cell population and/or that employ a particular bioreactor having a gas permeable membrane.
    Type: Application
    Filed: December 6, 2022
    Publication date: April 13, 2023
    Inventors: Ann Marie Leen, Ulrike Gerdemann, Cliona M. Rooney, Juan F. Vera Valdes, John R. Wilson
  • Patent number: 11613725
    Abstract: Improved cell culture devices and related methods that overcome the limitations of prior devices and methods, by creating devices that can integrate a variety of novel attributes. These various attributes include the use of gas permeable material and medium volumes that exceed conventional devices as well as compartments that can facilitate the long term study of high density cultures with reduced disruption of the culture environment, the ability to study the migration of items of interest including substances such as chemokine, track the movement of cells, and monitor cell to cell interactions.
    Type: Grant
    Filed: May 9, 2016
    Date of Patent: March 28, 2023
    Assignee: Wilson Wolf Manufacturing
    Inventors: John R. Wilson, Daniel P. Welch
  • Patent number: RE49293
    Abstract: Gas permeable devices and methods are disclosed for cell culture, including cell culture devices and methods that contain medium at heights, and certain gas permeable surface area to medium volume ratios. These devices and methods allow improvements in cell culture efficiency and scale up efficiency.
    Type: Grant
    Filed: June 12, 2018
    Date of Patent: November 15, 2022
    Assignee: Wilson Wolf Manufacturing
    Inventors: John R. Wilson, Douglas A. Page, Daniel Welch, Alison Robeck